Posted in | News | Semiconductor

Ceradyne Complete Acquisition of Boron Products Specialist

Ceradyne, Inc. announced today that it has completed its previously announced acquisition of EaglePicher Boron LLC ("EP Boron") located in Quapaw, Oklahoma for $69.6 million in cash. EP Boron was established in the early 1970s to produce the boron isotope 10B. This isotope is a strong neutron absorber and is used for both nuclear waste containment and nuclear power plant neutron radiation control. EP Boron also produces complementary chemical isotopes used in the normal operation and control of nuclear power plants. The remaining boron isotope produced by EP Boron is 11B which is used as an additive to semiconductor grade silicon as a "doping" agent and in other semiconductor processes where ultra high purity boron is required. This growing market currently accounts for approximately 40% of EP Boron sales.

EP Boron will be operated as a wholly owned subsidiary of Ceradyne, Inc. reporting to Michael Kraft. In June 2007, Mr. Kraft was appointed vice president of the company's nuclear and semiconductor business units.

Joel P. Moskowitz, Ceradyne's chairman and chief executive officer, said: "I am very pleased with this latest Ceradyne acquisition, which meets our diversification objectives and provides us with a strategic opportunity that supports our continued expansion into both the nuclear waste containment and semiconductor arenas. Each of these markets shows considerable promise in the company's future, and I am confident that Michael's business development experience in these industries will prove resourceful."

Michael Kraft commented, "This acquisition fits perfectly with Ceradyne's longer range global strategy. We will be developing plans to accelerate EP Boron's global growth with the assistance of their very capable management team."

As previously disclosed, EP Boron's sales were approximately $23.0 million in its fiscal year ended November 30, 2006, with strong operating margins.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.